{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:02:23Z","timestamp":1789498943358,"version":"build-2803163510"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"abstract":"<jats:p>\n                    MicroRNAs (miRNAs) are implicated in breast cancer progression and prognosis. This study employed a Mendelian randomization (MR) framework to investigate causal relationships between plasma circulating miRNAs and breast cancer. miRNA expression quantitative trait loci were extracted from 2 independent cohorts. High-confidence miRNAs and their associated single-nucleotide polymorphisms were selected for 2-sample MR analyses using inverse-variance weighted and MR-Egger methods. Differential expression analysis and univariate Cox regression identified survival-associated genes in breast cancer, while enrichment analyses revealed pathways and biological processes linked to candidate targets. Pan-cancer analyses of miRNAs and targets were conducted via the ENCORI platform. Initial MR analyses in the discovery phase identified hsa-miR-100-5p, hsa-miR-125b-5p, and hsa-miR-339-5p as significantly associated with reduced breast cancer risk (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05), suggesting potential protective roles. A total of 1291 survival-associated differentially expressed genes were identified, with 39 overlapping targets implicated in miRNA-mediated breast cancer intervention. Enrichment analyses highlighted their involvement in cell cycle regulation and p53 signaling pathway. In the validation cohort, only hsa-miR-339-5p confirmed a protective effect on breast cancer risk, while hsa-miR-100-5p and hsa-miR-125b-5p did not reach significance. Pan-cancer profiling demonstrated aberrant miRNA expression across malignancies, prognostic relevance in multiple cancers, and significant negative correlations between miRNAs and target genes in breast tumors. Our findings provide novel insights into the causal roles of miRNAs in breast cancer pathogenesis and underscore their potential as noninvasive biomarkers and therapeutic targets. Future studies should prioritize functional validation and clinical translation of these miRNAs.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047494","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:01:30Z","timestamp":1770404490000},"page":"e47494","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Identification of putative causal associations between MicroRNAs and breast cancer via Mendelian randomization and bioinformatic analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Jianlin","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Shaoxing Shangyu District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3797-237X","authenticated-orcid":false,"given":"Lifeng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Shaoxing Shangyu District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","first-page":"477","article-title":"Breast cancer statistics 2024.","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00259-024-07042-9","article-title":"Editorial commentary: should \u201cheterogeneous response\u201d be considered as new category for assessing treatment response in patients with breast cancer?","volume":"52","author":"Vaz","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s12282-024-01620-3","article-title":"Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?","volume":"31","author":"Altundag","year":"2024","journal-title":"Breast Cancer"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"e13700","DOI":"10.1111\/cpr.13700","article-title":"MCL restrained ROS\/AKT\/ASAH1 pathway to therapy tamoxifen resistance breast cancer by stabilizing NRF2.","volume":"57","author":"Han","year":"2024","journal-title":"Cell Prolif"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tcb.2023.05.009","article-title":"miRNA dosage control in development and human disease.","volume":"34","author":"Cui","year":"2024","journal-title":"Trends Cell Biol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12032-024-02579-z","article-title":"Advancing miRNA cancer research through artificial intelligence: from biomarker discovery to therapeutic targeting.","volume":"42","author":"Aswathy","year":"2024","journal-title":"Med Oncol"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"e2146","DOI":"10.1002\/biof.2146","article-title":"Role of miRNAs in breast cancer development and progression: current research.","volume":"51","author":"Kumar","year":"2025","journal-title":"Biofactors"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/ijo.2024.5713","article-title":"MicroRNAs and their role in breast cancer metabolism (Review).","volume":"66","author":"Lee","year":"2025","journal-title":"Int J Oncol"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.3390\/cells10123504","article-title":"Identifying putative causal links between microRNAs and severe COVID-19 using Mendelian randomization.","volume":"10","author":"Li","year":"2021","journal-title":"Cells"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1007\/s10072-023-06860-3","article-title":"Evaluating the causal association between microRNAs and amyotrophic lateral sclerosis.","volume":"44","author":"Zhu","year":"2023","journal-title":"Neurol Sci"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"1385675","DOI":"10.3389\/fnins.2024.1385675","article-title":"Systematic genome-wide Mendelian randomization reveals the causal links between miRNAs and Parkinson\u2019s disease.","volume":"18","author":"Shi","year":"2024","journal-title":"Front Neurosci"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1038\/s41598-023-38886-0","article-title":"Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort.","volume":"13","author":"Chiorino","year":"2023","journal-title":"Sci Rep"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.31557\/APJCP.2021.22.5.1375","article-title":"Plasma circulating mirnas profiling for identification of potential breast cancer early detection biomarkers.","volume":"22","author":"Jusoh","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"e1092","DOI":"10.1002\/mgg3.1092","article-title":"Plasma-based microRNA signatures in early diagnosis of breast cancer.","volume":"8","author":"Li","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1038\/ncomms7601","article-title":"Genome-wide identification of microRNA expression quantitative trait loci.","volume":"6","author":"Huan","year":"2015","journal-title":"Nat Commun"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cvr\/cvz030","article-title":"Genome-wide identification of circulating-miRNA expression quantitative trait loci reveals the role of several miRNAs in the regulation of cardiometabolic phenotypes.","volume":"115","author":"Nikpay","year":"2019","journal-title":"Cardiovasc Res"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","article-title":"miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology.","volume":"48","author":"Chang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"D147","DOI":"10.1093\/nar\/gkae1072","article-title":"miRTarBase 2025: updates to the collection of experimentally validated microRNA-target interactions.","volume":"53","author":"Cui","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data.","volume":"19","author":"Xu","year":"2024","journal-title":"Nat Protoc"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.2147\/IJGM.S361981","article-title":"Exosome-derived miRNAs as potential biomarkers for prostate bone metastasis.","volume":"15","author":"Lu","year":"2022","journal-title":"Int J Gen Med"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"e24010","DOI":"10.1002\/jcla.24010","article-title":"Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues.","volume":"35","author":"Mahmoudian","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.gendis.2019.09.002","article-title":"Identification of miRNA signature associated with BMP2 and chemosensitivity of TMZ in glioblastoma stem-like cells.","volume":"7","author":"Guo","year":"2020","journal-title":"Genes Dis"},{"key":"R24-20260915","first-page":"1509","article-title":"Bioinformatics analyses combined microarray identify the desregulated microRNAs in lung cancer.","volume":"17","author":"Guo","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/cancers16010129","article-title":"Increased hsa-miR-100-5p expression improves hepatocellular carcinoma prognosis in the asian population with PLK1 variant rs27770A>G.","volume":"16","author":"Liao","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/jcm12010322","article-title":"Identification of three circulating microRNAs in plasma as clinical biomarkers for breast cancer detection.","volume":"12","author":"Wang","year":"2022","journal-title":"J Clin Med"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"101623","DOI":"10.1016\/j.tice.2021.101623","article-title":"Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p.","volume":"73","author":"Ding","year":"2021","journal-title":"Tissue Cell"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"736274","DOI":"10.3389\/fcell.2021.736274","article-title":"Comprehensive analysis of the prognostic significance of Hsa-miR-100-5p and its related gene signature in stomach adenocarcinoma.","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1002\/hed.25866","article-title":"MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.","volume":"41","author":"Jakob","year":"2019","journal-title":"Head Neck"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/cam4.1129","article-title":"Clinical value of integrated-signature miRNAs in esophageal cancer.","volume":"6","author":"Zhang","year":"2017","journal-title":"Cancer Med"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"5468672","DOI":"10.1155\/2018\/5468672","article-title":"A panel of microRNA signature as a tool for predicting survival of patients with urothelial carcinoma of the bladder.","volume":"2018","author":"Inamoto","year":"2018","journal-title":"Dis Markers"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.yexcr.2015.09.015","article-title":"Progress on the relationship between miR-125 family and tumorigenesis.","volume":"339","author":"Yin","year":"2015","journal-title":"Exp Cell Res"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.3390\/ijms24119175","article-title":"The role of hsa-miR-125b-5p interaction with S1P\/ceramide axis in the potential development of inflammation-associated colon cancer in primary sclerosing cholangitis.","volume":"24","author":"Abramczyk","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"108696","DOI":"10.1016\/j.compbiomed.2024.108696","article-title":"Identifying miRNA as biomarker for breast cancer subtyping using association rule.","volume":"178","author":"Md Zaki","year":"2024","journal-title":"Comput Biol Med"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12935-023-02888-9","article-title":"Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation.","volume":"23","author":"Lin","year":"2023","journal-title":"Cancer Cell Int"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"1101041","DOI":"10.3389\/fcell.2023.1101041","article-title":"Expression profile of miRNAs computationally predicted to target PDL-1 in cervical tissues of different histology groups.","volume":"11","author":"Leventakou","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"596826","DOI":"10.3389\/fgene.2020.596826","article-title":"Identification of key microRNAs and mechanisms in prostate cancer evolution based on biomarker prioritization model and carcinogenic survey.","volume":"11","author":"Lin","year":"2020","journal-title":"Front Genet"},{"key":"R38-20260915","first-page":"1159","article-title":"Screening miRNAs for early diagnosis of colorectal cancer by small RNA deep sequencing and evaluation in a Chinese patient population.","volume":"9","author":"Wang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.2147\/OTT.S163891","article-title":"Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis.","volume":"11","author":"Zhou","year":"2018","journal-title":"Onco Targets Ther"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1007\/s13277-015-4550-4","article-title":"MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.","volume":"37","author":"Ozcan","year":"2016","journal-title":"Tumour Biol"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3389\/fcell.2020.00688","article-title":"The construction and analysis of ceRNA network and patterns of immune infiltration in colon adenocarcinoma metastasis.","volume":"8","author":"Chang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"e000376","DOI":"10.1136\/jitc-2019-000376","article-title":"Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR\/ALK wild-type advanced non-small cell lung cancer.","volume":"8","author":"Peng","year":"2020","journal-title":"J ImmunoTher Cancer"},{"key":"R43-20260915","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/acsomega.2c07480","article-title":"Z-Guggulsterone induces cell cycle arrest and apoptosis by targeting the p53\/CCNB1\/PLK1 pathway in triple-negative breast cancer.","volume":"8","author":"Wu","year":"2023","journal-title":"ACS Omega"},{"key":"R44-20260915","doi-asserted-by":"crossref","first-page":"101856","DOI":"10.1016\/j.toxrep.2024.101856","article-title":"Gossypol enhances ponatinib\u2019s cytotoxicity against human hepatocellular carcinoma cells by involving cell cycle arrest, p-AKT\/LC3II\/p62, and Bcl2\/caspase-3 pathways.","volume":"14","author":"Elkattan","year":"2025","journal-title":"Toxicol Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:03:33Z","timestamp":1789495413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047494","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"2025-09-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}